Company / CapEx per Share
GeneDx Holdings Corp. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.68
FY2025
5-year range
$0.21 / $75806.45
FY2021-FY2025
Trend
+221.1%
vs FY2024
Sector context
#77 of 142
Health Care
What the data says
CapEx per Share changed +221% YoY in FY2025, a notable deviation from the 6-year average annual change of +232%.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -82.9%.
Improved from $0.45 to $0.68 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -92.1%
- 5-Year CAGR
- -82.9%
- 10-Year CAGR
- -
Sector benchmark
#77 of 142 in Health CareTop 54% of 142This company $0.68 Sector average $1.70
▼
-60.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 221.1% year-over-year.
- Ranks #77 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +221.1% |
| FY2024 | $0.21 | -52.6% |
| FY2023 | $0.45 | -100.0% |
| FY2022 | $1394.66 | -98.2% |
| FY2021 | $75806.45 | +1514.4% |
| FY2020 | $4695.77 | -95.1% |
| FY2019 | $96153.23 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026